Cardiology Clinic Trends 2026: When Meeting Requirements Decides Whether You Can Bill

Cardiology treats conditions — hypertension, arrhythmia, heart failure — that require long-term control rather than cure. Once a physician-patient relationship forms, it tends to be stable. High return-visit rates are a structural strength and the foundation of revenue.

But the FY2026 revision introduced a cluster of items to this specialty where you cannot bill unless you meet the requirements.

1. Macro environment — more openings, but also more attrition

Japan has 105,519 general clinics (as of end-August 2025), of which 100,336 have no beds — surpassing 100,000 for the first time. Clinics with beds fell from 5,958 in Reiwa 4 to 5,183, indicating that new openings skew toward bed-free, specialized practices.

The environment is not comfortable. Only 66.6% of medical clinics operate in the black, and roughly half of clinics with beds run operating losses. In 2024, a record 722 medical institutions closed or dissolved (587 of them clinics), with owner ageing and lack of a successor as the leading cause.

Two regulatory issues dominate.

First, healthcare DX became effectively mandatory as of June 1, 2026. Support for the electronic medical record information sharing service is now effectively required, and clinics without it are expected to lose access to related add-on fees.

Second, the FY2026 fee schedule revision — restructuring the lifestyle disease management fee, creating a heart failure readmission prevention fee, and revising CPAP home management requirements — directly affects both revenue structure and workflow.

2. Characteristics of newly opened clinics

Cardiology is considered relatively less contested than other internal medicine fields. Patients tend to trust large institutions such as university hospitals, but because the conditions require long-term control, patients stay once a relationship is established.

Initial investment is on the heavier end of internal medicine.

Physician income is estimated at ¥20–30 million. Echocardiography is the most expensive item, and buying demo or exhibition units is a recommended cost lever.

The success factor cited most often is securing patients before opening. Building a patient base through public hospital practice and transferring them via referral at opening is described as most effective, with continued part-time clinics at the former hospital (roughly weekly) maintaining hospital-clinic ties.

Differentiators include cardiac rehabilitation, home and remote ECG monitoring, visiting care capability, and booking systems and online consultation. In short, the archetype is referral networks from hospital practice × substantial diagnostic equipment investment × high return-visit rates from chronic disease management.

3. Revenue areas specific to cardiology

Chronic lifestyle disease management

Base points were held: lifestyle disease management fee (I) at 610 for dyslipidemia, 660 for hypertension, 760 for diabetes; fee (II) at 333. But fee (I) now explicitly requires blood testing at least once every six months, while the patient signature requirement on care plans was eliminated. New ophthalmology and dental coordination add-ons (60 points each, once yearly) were created, and narrowed bundling allows separate fee-for-service billing of items such as the specific drug treatment management fee.

For cardiology practices seeing large hypertension populations, eliminating signatures cuts administrative load while the six-month testing requirement forces a redesign of test workflows to prevent omissions.

Heart failure readmission prevention fee (new)

A new revenue opportunity arrived with a high bar attached.

Outpatient billing is capped at one year from first use and limited to patients for whom fee 1 was billed during admission within the preceding six months — meaning coordination with acute care hospitals is a prerequisite. Facility standards require appropriate staffing of physicians, nurses (or public health nurses), pharmacists, and registered dietitians; fee 2 additionally requires physicians and nurses with a defined number of years of heart failure care experience. The pharmacist and dietitian requirement is a significant barrier for most clinics, making billing difficult in isolation. Building regional coordination becomes a management problem in itself.

Cardiac rehabilitation

For Reiwa 8, the cardiovascular rehabilitation fee is 205 points per unit for (I) and 125 for (II), conditional on meeting and filing facility standards. Maintenance-phase outpatient rehabilitation carries constraints such as unit caps. Clinics that promote cardiac rehabilitation at opening tend to position it as both a retention mechanism and a receiving point for insured and self-pay services.

CPAP home management for sleep apnea

Because sleep apnea is closely linked to hypertension, arrhythmia, and heart failure, cardiology clinics increasingly absorb SAS care.

Under the FY2026 revision, home CPAP management fee 2 fell from 250 to 240 points, but the new CPAP enhanced management structure add-on of 15 points brings the total to 255 — a net increase for clinics with the structure in place. The AHI threshold for eligible patients dropped from roughly 20 to 15, and a new usage-based restriction bars billing when average daily use is under one hour across all of the preceding three months.

Facility standards for the enhanced add-on include using devices capable of remotely monitoring usage time and AHI, plus a usage track record (months with 20+ days of 4+ hour usage making up at least 40% of managed months over the preceding three months). Combining remote monitoring with online consultation to manage CPAP patients continuously while limiting travel burden is becoming the standard model.

Home care, online consultation, and screening inflow

Following elderly heart failure patients through visiting care fits naturally, and stable lifestyle disease and SAS patients are increasingly managed through online consultation and remote monitoring. Directing patients flagged for ECG or blood pressure abnormalities at health checks into insured workup and ongoing management remains the classic acquisition route.

4. Self-pay services

Compared with aesthetic specialties, self-pay is intrinsically limited in cardiology. Core conditions are insured, and insured care accounts for the bulk of revenue. Self-pay enters mainly through prevention and screening, and through obesity and metabolic care.

First, cardiac and cardiovascular screening packages. One specialist clinic offers screening at ¥33,000, basic-light at ¥55,000, basic at ¥77,000, and premium at ¥143,000, progressively incorporating echocardiography, PWV/ABI arterial stiffness measurement, carotid ultrasound, cardiopulmonary exercise testing, and chest/abdominal CT or MRI-MRA. Options include Holter monitoring at ¥24,200, sleep apnea testing at ¥11,000, and coronary CT angiography at ¥52,800–86,900. Its function is as an entry point bridging asymptomatic at-risk patients into insured ongoing management.

Second, self-pay obesity and metabolic clinics (GLP-1). One clinic runs a healthcare outpatient service at ¥8,900 for first visits and ¥750 for return visits plus drug costs, providing weight reduction support with GLP-1 and GIP/GLP-1 receptor agonists. That clinic explicitly positions pharmacotherapy as supplementary to diet and exercise — an approach consistent with primary prevention of lifestyle disease.

In short, self-pay in cardiology is peripheral revenue in prevention and metabolic care that complements insured practice. Restricting the menu to what sits continuously with insured care is the realistic design.

5. Management implications

First, the business remains anchored in insured "continuous management × diagnostics," and the basic strategy is maximizing the structural advantage of high return-visit rates. At opening, securing a patient base capable of repaying diagnostic equipment investment — built on referral networks and hospital ties — is the key move.

Second, the FY2026 revision ushered in an era where meeting requirements decides whether you can bill. The six-month blood testing requirement, the multidisciplinary staffing and coordination requirements for heart failure management, and the CPAP usage and remote monitoring conditions all fail to produce revenue unless structure and data management are in place.

Third, home care, online consultation, and remote monitoring — the retention infrastructure — determine competitiveness. Keep self-pay within the range continuous with insured care, such as cardiac screening and weight management, and treat it as a complement. Underlying all of this, healthcare DX including the EMR information sharing service is no longer optional but a condition of both billing and survival.

6. How an AI EMR addresses these problems — feature by feature

Nearly every challenge cardiology faces in 2026 comes down to one thing: can you show with data that you met the requirements? Blood test intervals, CPAP usage records, multidisciplinary documentation. Here is how Pottech's AI Karte takes that proof off your hands, feature by feature.

Feature 1: Billing and claims — don't leave requirement compliance to memory

An automated calculation engine checks bundling conflicts, exclusions, and frequency limits, and determines add-on eligibility automatically.

For lifestyle disease management fee (I), a missed six-month blood test invalidates the billing outright. In a clinic managing hundreds of hypertension patients, tracking every patient's last blood draw by hand is not realistic. A mechanism that surfaces overdue patients from order history is revenue protection. The same applies to the heart failure fee's one-year cap and six-month lookback condition, and to CPAP fee 2's rule barring billing when average daily use falls under one hour across three consecutive months — all are period-management problems.

Feature 2: Integrations and APIs — bring CPAP and ECG data into the chart

An OAuth2 gateway, MCP server, and HAPI FHIR enable integration with external systems and devices.

The CPAP enhanced management add-on's facility standards require devices capable of remotely monitoring usage time and AHI, plus an outcome-linked track record — months with 20+ days of 4+ hour usage making up at least 40% of the preceding three months. That requirement only exists if device data can be ingested and aggregated continuously. The same structure applies to home and remote ECG monitoring. In this specialty, device integration and data visibility are, literally, billing eligibility.

Feature 3: Patient PHR app integration ("Pote-kun") — support adherence

OCR capture of prescriptions with medication reminders, appointment booking, and LINE login with push notifications.

Shifting CPAP evaluation from "patients started" to "continuation and adherence" changed what the numbers mean. Leaving low-usage patients unattended erodes the track record the add-on depends on. Delivering usage feedback and reminders to patients supports both billing eligibility and retention. Medication continuity in hypertension and dyslipidemia, and self-measurement of weight and blood pressure in heart failure patients, run on the same framework.

Feature 4: AI assistant — summarize change in time-series data

Alongside diagnostic suggestions and differentials, it summarizes lab value trends and personalizes patient-facing explanations.

Cardiology follows multiple long-running time series — blood pressure, lipids, echo findings, Holter results, CPAP usage. Being able to summarize "what changed over these three months" rather than reading a list of numbers raises decision quality within limited consultation time. Generated patient explanations also support the persuasion-dependent processes: lifestyle disease care plans and cardiac screening results discussions.

Feature 5: Charting and orders — align records across professions

AI generates SOAP notes from consultation audio, and set orders enter tests and prescriptions in one action.

The heart failure readmission prevention fee sets multidisciplinary staffing — physicians, nurses, pharmacists, dietitians — as a facility standard. In multidisciplinary management, the record of who provided what guidance and when is the evidence behind the billing. When documentation granularity varies by profession, proving compliance becomes difficult. Standardizing record format through templates and voice input means more than time savings where multidisciplinary requirements apply.

Feature 6: Practice analytics — track add-on capture rates

Visit volume, revenue per patient, and monthly trends are aggregated and visualized automatically.

When meeting requirements decides billing, the management metrics change too. "What percentage of eligible patients did we actually bill the add-on for" matters more here than patient count. Lifestyle disease management fee capture rate, progress against the CPAP add-on's track record threshold, heart failure fee volume — following these monthly is how you measure your capacity to absorb the revision.

Primary sources

• Yuyama, "Clinic counts and future trends: healthcare DX as the key management issue" https://www.yuyama.co.jp/column/clinic/clinic-number/
• Okusuai Medical Business Development, "Cardiology clinic opening consulting" https://www.okusuai.co.jp/service/consulting-cardiology.html
• CLINICS, "Cardiology clinic opening strategy" https://clinics-cloud.com/column/433
• med-cpa, "FY2026 revision: lifestyle disease management fee changes explained" https://med-cpa.jp/hoshu-13/
• Funai Consulting, "The new heart failure readmission prevention fee in the 2026 revision" https://byoin-clinic-keiei.funaisoken.co.jp/blogs/column/life20260415-3
• Credo, "FY2026 revision: home CPAP management fee changes" https://www.credo-m.co.jp/column/detail/hosyu/25383/
• Knowlety, "Cardiovascular rehabilitation fee — FY2026 revision" https://knowlety.jp/ika/h000/
• Sakakibara Heart Institute Clinic, "Cardiovascular screening" https://sakakibara-heart-cl.jp/cardiovascular-dock.html